184 related articles for article (PubMed ID: 37586782)
1. The status and challenges of HPV vaccine programme in China: an exploration of the related policy obstacles.
Wang H; Jiang Y; Wang Q; Lai Y; Holloway A
BMJ Glob Health; 2023 Aug; 8(8):. PubMed ID: 37586782
[No Abstract] [Full Text] [Related]
2. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.
Wong LP; Han L; Li H; Zhao J; Zhao Q; Zimet GD
Hum Vaccin Immunother; 2019; 15(7-8):1533-1540. PubMed ID: 31017500
[TBL] [Abstract][Full Text] [Related]
3. Jabs for the boys: the case for gender-neutral HPV vaccination.
Baker P
Perspect Public Health; 2016 Jan; 136(1):28-9. PubMed ID: 26702116
[No Abstract] [Full Text] [Related]
4. The feasibility of universal HPV vaccination program in Shenzhen of China: a health policy analysis.
Chen R; Wong E
BMC Public Health; 2019 Jun; 19(1):781. PubMed ID: 31221112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
Constable C; Caplan A
Vaccine; 2020 Jan; 38(5):954-962. PubMed ID: 31843271
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.
Watson-Jones D; Lees S; Mwanga J; Neke N; Changalucha J; Broutet N; Maduhu I; Kapiga S; Chandra-Mouli V; Bloem P; Ross DA
Health Policy Plan; 2016 Jul; 31(6):691-9. PubMed ID: 26768827
[TBL] [Abstract][Full Text] [Related]
7. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
8. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
10. Early lessons learned from extramural school programs that offer HPV vaccine.
Hayes KA; Entzel P; Berger W; Caskey RN; Shlay JC; Stubbs BW; Smith JS; Brewer NT
J Sch Health; 2013 Feb; 83(2):119-26. PubMed ID: 23331272
[TBL] [Abstract][Full Text] [Related]
11. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.
Laugesen MJ; Mistry R; Carameli KA; Ribisl KM; Needleman J; Bastani R
J Adolesc Health; 2014 Nov; 55(5):659-64. PubMed ID: 24928803
[TBL] [Abstract][Full Text] [Related]
12. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.
Dorleans F; Giambi C; Dematte L; Cotter S; Stefanoff P; Mereckiene J; O'Flanagan D; Lopalco PL; D'Ancona F; Levy-Bruhl D;
Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144444
[TBL] [Abstract][Full Text] [Related]
13. Another look at the human papillomavirus vaccine experience in Canada.
Mah CL; Deber RB; Guttmann A; McGeer A; Krahn M
Am J Public Health; 2011 Oct; 101(10):1850-7. PubMed ID: 21852642
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
15. The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations.
Moghtaderi A; Adams S
Appl Health Econ Health Policy; 2016 Jun; 14(3):349-59. PubMed ID: 26873090
[TBL] [Abstract][Full Text] [Related]
16. The Expanded Impact of Human Papillomavirus Vaccine.
Pahud BA; Ault KA
Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.
Wigle J; Coast E; Watson-Jones D
Vaccine; 2013 Aug; 31(37):3811-7. PubMed ID: 23777956
[TBL] [Abstract][Full Text] [Related]
18. Challenging 'girls only' publicly funded human papillomavirus vaccination programmes.
Law VG; Gustafson DL
Nurs Inq; 2017 Jan; 24(1):. PubMed ID: 27198909
[TBL] [Abstract][Full Text] [Related]
19. Progress in HPV vaccination in low- and lower-middle-income countries.
LaMontagne DS; Bloem PJN; Brotherton JML; Gallagher KE; Badiane O; Ndiaye C
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():7-14. PubMed ID: 28691329
[TBL] [Abstract][Full Text] [Related]
20. Australia leads way on HPV vaccination in boys.
Wilkinson E
Lancet Infect Dis; 2012 Nov; 12(11):831-2. PubMed ID: 23256210
[No Abstract] [Full Text] [Related]
[Next] [New Search]